This is the question we get asked most often, usually phrased carefully, and it usually means one specific thing: can I do this instead of taking medication?
We are going to answer it directly, because you deserve a real answer more than we deserve a sale.
The short version
For ADHD, the head-to-head research favors medication. Not by a little, and not ambiguously.
If your goal is to replace a prescribed ADHD medication with neurofeedback, the evidence does not support that plan, and we are not going to pretend otherwise to get you in the door.
Here is what that conclusion rests on.
What the head-to-head trials found
A small number of randomized trials have compared neurofeedback directly against stimulant medication in children and adolescents with ADHD. A 2018 systematic review in Neuropsychiatric Disease and Treatment pulled them together.
Of the head-to-head trials it reviewed, three found stimulant medication superior to neurofeedback on behavioral assessments. Two found both groups improved with no significant difference between them. None found neurofeedback superior.
The pattern gets sharper in the better-designed trials. The review noted that the trials which titrated stimulants properly, using double-blind placebo-controlled titration to find the right dose, were the ones where medication came out clearly ahead on both behavioral and neurocognitive outcomes.
One of those is worth quoting on its own. A 2013 randomized pilot in the Journal of Child and Adolescent Psychopharmacology took 32 medication-naive patients aged 7 to 16 and randomized them to either 30 sessions of neurofeedback or drug treatment. The authors’ conclusion: “Our study supports effects for stimulants, but not for NF.”
The review’s overall assessment, in its own words: when you restrict to trials with probably blinded ratings, or sham-controlled designs, or optimal titration procedures, “the findings do not support theta/beta NF as a standalone treatment for children or adolescents with ADHD.”
The bigger picture behind it
The head-to-head trials are consistent with the larger body of evidence on neurofeedback and ADHD, which is not encouraging.
In 2024 the European ADHD Guidelines Group published a meta-analysis in JAMA Psychiatry pooling 38 randomized trials covering 2,472 people. Restricted to reports from raters who were probably unaware of who had been treated, neurofeedback showed no significant improvement in total ADHD symptoms: a standardized effect of 0.04, confidence interval -0.10 to 0.18.
Their conclusion: “Overall, neurofeedback did not appear to meaningfully benefit individuals with ADHD, clinically or neuropsychologically, at the group level.”
So the comparison is not a close race that we are conceding out of modesty. Medication has evidence behind it for ADHD. Standalone neurofeedback, under the conditions where researchers can actually tell signal from expectation, does not.
Being fair about the limits of that comparison too
Honesty cuts in both directions, so a few caveats belong here.
There are not many head-to-head trials, and the ones that exist were mostly not powered to detect differences between treatments in the first place. The reviewers say so plainly: “studies were not powered to detect differences.”
The trials also vary in protocol, session count, patient selection, and how carefully the medication arm was dosed. And there is a known bias running the other way in some of this literature: where trials used suboptimal titration, the reviewers note that stimulant effects may be underestimated, which if anything flatters neurofeedback rather than the reverse.
There is also the recurring question of how much of any behavioral improvement is the training itself versus what surrounds it. As one review puts it, the debate “concerns whether behavioural improvements are the result of specific NF treatment effects or nonspecific treatment effects, that is, placebo effects, such as therapist engagement or personal motivation.” Parent-reported gains in particular tend to shrink or vanish when the rater is blinded.
None of those caveats rescue a “neurofeedback instead of medication” plan. They just mean the comparison is built on a thinner literature than anyone would like.
Where neurofeedback is actually studied
The role the research describes for neurofeedback in ADHD is complementary: part of a multimodal plan, individualized to the person, rather than a standalone treatment or a swap for something else.
That framing is not unique to ADHD. Where a neurofeedback-based technology has been cleared by the FDA for post-traumatic stress, it was cleared as an adjunctive therapy, meaning for use alongside other treatment such as psychotherapy and pharmacotherapy. The PTSD literature describes it the same way.
Neurofeedback is a procedure, not a drug, so it is not something the FDA approves, and it is not FDA approved as a treatment for any specific condition. It is not a cure.
The part that actually matters for your safety
Please do not change, reduce, or stop a prescribed medication based on anything you read on a clinic’s website, including ours.
If medication is not working well for you, or the side effects are hard to live with, that is a real problem and it is worth raising. Raise it with the person who prescribed it. They have options, and those options are theirs to weigh with you.
We say “drug-free” about our own service because that is a description of what neurofeedback is: no medication involved. It is not a claim about what it can take the place of, and we would be misleading you if we let it drift into one.
Does the answer change by condition?
The evidence for neurofeedback does vary a lot by condition, and it is stronger elsewhere than it is for attention. Post-traumatic stress has the strongest published research in the field, and anxiety is next. We wrote that up honestly, caveats included, in does neurofeedback actually work.
But note what that is and is not. It is a statement about neurofeedback’s own evidence base. It is not a head-to-head comparison against medication for those conditions, and we are not making one. The same rule applies across the board: we are not a substitute for prescribed treatment, and we work alongside your medical and mental health care rather than in place of it.
What we can actually offer you
Something more modest than a replacement, and more concrete than a promise.
A qEEG brain map measures how your own brain rhythms are behaving rather than assuming a generic pattern. You then sit down with Dr. Cindy Morrey for a results review in plain language, and if training makes sense we build a plan around what your map actually shows.
If your prescriber is part of your care, they stay part of it. We would rather be the clinic that told you medication had the better evidence and earned your trust anyway.
Sources
- Razoki B. Neurofeedback versus psychostimulants in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a systematic review. Neuropsychiatric Disease and Treatment. 2018;14:2905-2913.
- Ogrim G, Hestad KA. Effects of neurofeedback versus stimulant medication in attention-deficit/hyperactivity disorder: a randomized pilot study. Journal of Child and Adolescent Psychopharmacology. 2013;23(7):448-457.
- Westwood SJ, Aggensteiner PM, Kaiser A, et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024;82(2):118-129.
- Voigt JD, Mosier M, Tendler A. Systematic review and meta-analysis of neurofeedback and its effect on posttraumatic stress disorder. Frontiers in Psychiatry. 2024;15:1323485.
- U.S. Food and Drug Administration, 21 CFR Part 882, Neurological Devices.
A little more clarity
Your questions.
Can neurofeedback replace my ADHD medication?
We will not tell you that it can. In the randomized trials that compared them head-to-head, stimulant medication generally performed better than neurofeedback on core ADHD symptoms, and in the largest blinded meta-analysis neurofeedback showed no significant benefit at all. Never change or stop a prescribed medication based on a website. That is a conversation for you and your prescriber.
What does it mean when neurofeedback is described as drug-free?
It means the procedure itself involves no medication. That describes what neurofeedback is, not what it can replace. The evidence does not support treating it as a substitute for prescribed ADHD treatment, and we do not market it as one.
Where does neurofeedback fit alongside medication then?
The research describes its role as complementary, meaning part of a broader plan rather than a standalone treatment or a swap. That is also how the one FDA-cleared neurofeedback technology for post-traumatic stress is cleared: as an adjunctive therapy, used alongside other treatment.
Does the answer change for conditions other than ADHD?
The evidence picture does change by condition. Post-traumatic stress and anxiety are where neurofeedback's own research is strongest. But that is a statement about neurofeedback's evidence, not a comparison against medication for those conditions, and we do not make claims about substituting for any prescribed treatment.